Churchill Capital Corp Xi Cl A (CCXI)
Churchill Capital Corp Xi Cl A (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCXI | NAMS | CORT | ||
| Company | Churchill Capital Corp Xi Cl A | Newamsterdam Pharma Company N.V. | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.19 | 34.89 | 34.61 | ||
| High | 10.19 | 36.26 | 35.78 | ||
| Low | 10.18 | 34.57 | 34.21 | ||
| Latest | 10.18 | 36.17 | 35.34 | ||
| Change | -0.01 | +0.59 | +0.52 | ||
| % Change | -0.10% | +1.66% | +1.49% | ||
| Volume | 1,183 | 796,597 | 1,673,248 | ||
| 20-Day Average Volume | N/A | 636,805 | 2,093,042 | ||
| Previous Close | 10.19 | 35.58 | 34.82 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 33.72 | 40.41 | ||
| 20-Day Raw Stochastic | N/A | 78.10% | 36.30% | ||
| 20-Day Relative Strength | N/A | 56.62 | 35.02 | ||
| Weighted Alpha | N/A | +88.94 | -24.82 | ||
| Today's Opinion | N/A | 56% Buy | 100% Sell | ||
| Previous Opinion | N/A | 56% Buy | 100% Sell | ||
| Last Month's Opinion | N/A | 56% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.10% since 02/13/26 | +4.45% since 02/13/26 | -11.58% since 02/13/26 | ||
| Low | 10.18 on 02/23/26 | 33.51 on 02/19/26 | 28.66 on 02/19/26 | ||
| High | 10.26 on 02/17/26 | 37.76 on 02/18/26 | 40.51 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | N/A since 02/09/26 | +8.55% since 01/23/26 | -19.65% since 01/23/26 | ||
| Low | 10.07 on 02/09/26 | 30.50 on 01/30/26 | 28.66 on 02/19/26 | ||
| High | 10.45 on 02/10/26 | 37.76 on 02/18/26 | 47.06 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | N/A since 02/09/26 | -5.49% since 11/21/25 | -54.28% since 11/21/25 | ||
| Low | 10.07 on 02/09/26 | 30.17 on 01/20/26 | 28.66 on 02/19/26 | ||
| High | 10.45 on 02/10/26 | 42.00 on 11/26/25 | 89.00 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | N/A since 02/09/26 | +44.68% since 08/22/25 | -49.75% since 08/22/25 | ||
| Low | 10.07 on 02/09/26 | 23.05 on 09/15/25 | 28.66 on 02/19/26 | ||
| High | 10.45 on 02/10/26 | 42.00 on 11/26/25 | 91.00 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,709,799 | 4,034,452 | 3,662,646 | ||
| Shares Outstanding, K | 71,356 | 113,391 | 105,188 | ||
| Annual Sales | 32,220,000 | 45,560,000 | 675,040,000 | ||
| Annual Net Income | -131,760,000 | -241,600,000 | 141,210,000 | ||
| Last Quarter Sales | 11,760,000 | 350,000 | 207,640,000 | ||
| Last Quarter Net Income | -31,650,000 | -72,010,000 | 19,670,000 | ||
| 60-Month Beta | 1.22 | 0.06 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 08/09/22 | -0.41 on 11/05/25 | 0.16 on 11/04/25 | ||
| Latest Earnings Date | 11/08/22 | 05/14/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 38.91 | ||